Dopamine D2 receptor-mediated Akt/PKB signalling: Initiation by the D2S receptor and role in quinpirole-induced behavioural activation

ASN Neuro

Volumn 4, Issue 6, 2012, Pages 371-382

  Chen, Han Ting ^a   Ruan, Nan Yu ^a   Chen, Jin Chung ^a   Lin, Tzu Yung ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Akt (protein kinase B); Dopamine D2S receptor; Glycogen synthase kinase 3; Nucleus accumbens; Receptor internalization

Indexed keywords

DOPAMINE 2 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; MALE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SERINE; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSFECTION;

EID: 84867591609     PISSN: 17590914     EISSN: None     Source Type: Journal    
DOI: 10.1042/AN20120013     Document Type: Article

References (44)

1. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 7:261-269.
2. Alessi DR, Downes CP (1998) The role of PI 3-kinase in insulin action. Biochim Biophys Acta 1436:151-164.
3. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217.
4. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273.
5. Beaulieu JM, Gainetdinov RR, Caron MG (2007) The Akt-GSK3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166-172.
6. Beaulieu, JM, Gainetdinov RR, Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327-347.
7. Belham C, Wu S, Avruch J (1999) Intracellular signaling: PDK1: a kinase at the hub of things. Curr Biol 9:R93-R96.
8. Beom S, Cheong D, Torres G, Caron MG, Kim KN (2004) Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase. J Biol Chem 279:28304-28314.
9. Buttrick GJ, Beaumont LMA, Leitch J, Yau C, Hughes JR, Wakefield JG (2008) Akt regulates centrosome migration and spindle orientation in the early Drosophila melanogaster embryo. J Cell Biol 180:537-548.
10. Castellino RC, Durden DL (2007) Mechanisms of disease: the PI3K-Akt-PTEN signaling node-an intercept point for the control of angiogenesis in brain tumors. Nat Neurol 3:682-693.
11. Chen PP, Chen JC (2005) Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 30:538-549.
12. Chen JC, Su HJ, Huang LI, Hsieh MC (1999) Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization. Life Sci 64:343-354.
13. Chen S, Zhang X, Yang D, Du Y, Li L, Li X, Ming M, Le W (2008) D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenoneinduced apoptosis through inhibition of caspase-and JNK-dependent pathways. FEBS Lett. 582:603-610.
14. Conrad PW, Millhorn DE, Beitner-Johnson D (2000) Novel regulation of p38γ by dopamine D2 receptor during hypoxia. Cell Signalling 12:463-467.
15. Dal TR, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025-4034.
16. De Mei C, Ramos M, Litata C, Borrelli E (2009) Getting specialized: presynaptic and postsynaptic dopamine D2 receptor. Curr Opin Pharmacol 9:53-58.
17. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends Neurosci 30:188-193.
18. Jope RS (2002) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441-443.
19. Karam CS, Ballon, JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, Markx S, Lieberman JA, Javitch JA (2010) Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol Sci 31:381-390.
20. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Kanki R, Yamashita H, Akaike A (2002) Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J Neurosci Res 70:274-282.
21. Kim SJ, Kim MY, Lee EJ, Ahn YS, Baik JH (2004) Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoform of the dopamine D2 receptor. Mol Endocrinol 18:640-652.
22. La Cour CM, Salles MJ, Pasteau V, Millan MJ (2011) Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D2 and D3 receptors. Mol Pharmacol 79:91-105.
23. Lim JH, Kim KM, Kim SW, Huang O, Choi H. J (2008) Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacol Res 57:325-331.
24. Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G (2003) Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 100:4305-4309.
25. Luo Y, Kokkonen GC, Wang X, Neve KA, Roth GS (1998) D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 71:980-990.
26. Martelli AM, Capitani S, Neri LM (1999) The generation of lipid signaling molecules in the nucleus. Prog Lipid Res 38:273-308.
27. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
28. Montmayeur JP, Bausero P, Amlaiky N, Maroteaux L, Hen R, Borrelli E (1991) Differential expression of the mouse D2 dopamine receptor isoforms. FEBS Lett 278:239-243.
29. Nair VD, Olanow W (2008) Differential modulation of Akt/glycogen synthase kinase-3b pathway regulates apoptotic and cytoprotective signaling responses. J Biol Chem 283:15469-15478.
30. Nair VD, Olanow W, Sealfon SC (2003) Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem J 373:25-32.
31. Nishi A, Snyder GL, Greengard P (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 17:8147-8155.
32. Paxinos G, Watson C (1996) The Rat Atlas in Stereotaxic Coordinates. Academic Press, San Diego.
33. Pippig S, Andexinger S, Lohse MJ (1995) Sequestration and recycling of β2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47:666-676.
34. Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya A, Lud Cadet J, Wong DF, Pletnikov MV (2011) Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology 60:1-10.
35. Quan W, Kim JH, Albert PR, Choi H, Kim KM (2008) Roles of G protein and β-arrestin in dopamine D2 receptor-mediated ERK activation. Biochem Biophy Res Commun 377:705-709.
36. Ray E, Samanta, AK (1996) Dansyl cadaverine regulates ligand induced endocytosis of interleukin-8 receptor in human polymorphonuclear neutrophils. FEBS Lett 378:235-239.
37. Schubert KM, Duronio V (2001) Distinct roles for extracellular-signalregulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesis. Biochem J 356:473-480.
38. Tan S, Hermann B, Borrelli E (2003) Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int Rev Neurobiol 54:145-197.
39. Wakefield JG, Stephens DJ, Tavaré JM (2003) A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 116:637-646.
40. Wang R, Brattain MG (2006) AKT can be activated in the nucleus. Cell Signalling 18:1722-1731.
41. Wang C, Buck DC, Yang R, Macey TA, Neve KA (2005) Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell typedependent transactivation of receptor tyrosine kinases. J Neurochem 93:899-909.
42. Wang Y, Xu R, Sasaoka T, Tonegawa S, Kung MP, Sankoorkai EB (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci 20:8305-8314.
43. Welter M, Vallone D, Samad TA, Meziane H, Usiello A, Borrelli E (2007) Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc Natl Acad Sci USA 104:6840-6845.
44. Woo CH, Kim TH, Choi JA, Ryu HC, Lee JE, You HJ, Bae YS, Kim JH (2006) Inhibition of receptor internalization attenuates the TNFα-induced ROS generation in non-phagocytic cells. Biochem Biophys Res Commun 351:972-978.